• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION HANCOCK; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION HANCOCK; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number HC150-12
Device Problems Gradient Increase (1270); Obstruction of Flow (2423)
Patient Problems Arrhythmia (1721); Atrial Fibrillation (1729); Non specific EKG/ECG Changes (1817); Pulmonary Regurgitation (2023); Ventricular Fibrillation (2130); Ventricular Tachycardia (2132); Stenosis (2263); Low Cardiac Output (2501); Complete Heart Block (2627)
Event Date 03/01/2019
Event Type  Injury  
Manufacturer Narrative
Citation: huang es et al.Rastelli operation for d-transposition of the great arteries, ventricular septal defect, and pulmonary stenosis.World j pediatr congenit heart surg.2019 mar 1;10(2):157-163.Doi: 10.1177/2150135118817765.Earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without the return of the product, no definitive conclusion can be made regarding the clinical observations.(b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding an evaluation of the long-term follow-up of patients who underwent the rastelli operation for dextro-transposition of the great arteries, ventricular septal defect, and pulmonary stenosis or pulmonary atresia.All data were collected and retrospectively reviewed from a single center between 1988 and 2017.The study population included 47 patients (predominantly male; mean age 3 years; mean weight 16 kg), 18 of which were implanted with a medtronic contegra valved conduit, 1 was implanted with a medtronic freestyle bioprosthesis, and 1 was implanted with a medtronic hancock valved conduit (no serial numbers provided).The literature characterized early mortality as ¿death during initial hospitalization or within 30 days of operation¿ and late mortality as ¿any deaths beyond 30 days after the initial rastelli operation and after discharge.¿ among all patients, 4 deaths occurred (1 early, 3 late).Multiple manufacturers were noted in the literature; based on the available information, medtronic product was not directly associated with the death(s).Among all patients, adverse events included: permanent pacemaker implantation (due to intermittent atrioventricular block, third-degree atrioventricular block, subaortic stenosis, sick sinus syndrome, atrial and ventricular fibrillation, complete heart block, first-degree atrioventricular delay, and right bundle branch block), early reoperation due to low cardiac output, subaortic stenosis resection/conduit replacement, conduit replacement/reintervention due to right ventricular outflow tract obstruction identified as either stenosis or pulmonary regurgitation, catheter-based conduit reintervention (balloon angioplasty, stent placement, and transcatheter pulmonary valve implant), catheter ablation for atrial tachycardia and left bundle branch morphology for ventricular tachycardia, cardiac transplantation, bacterial endocarditis (1 contegra case), moderate pulmonary regurgitation, mild left ventricular outflow tract obstruction, moderate conduit stenosis, and increased peak systolic gradients.Based on the available information, medtronic product may have been associated with the adverse event(s).No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HANCOCK
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key8542598
MDR Text Key142910151
Report Number2025587-2019-01326
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P790007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/23/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberHC150-12
Device Catalogue NumberHC150-12
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/02/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age3 YR
Patient Weight16
-
-